Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05580562
Title ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) (ACTION)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Chimerix
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | NLD | ITA | GBR | ESP | DEU | CAN | AUT | AUS


No variant requirements are available.